Holen Sie sich die Stockscreener-App
6.49
3.13%
-0.21
Schlusskurs vom Vortag:
$6.70
Offen:
$6.5
24-Stunden-Volumen:
22,478
Relative Volume:
0.32
Marktkapitalisierung:
$150.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.28%
1M Leistung:
-7.02%
6M Leistung:
-38.37%
1J Leistung:
-26.00%
1-Tages-Spanne:
$6.41
$6.66
1-Wochen-Bereich:
$6.295
$7.2872
52-Wochen-Spanne:
$5.47
$11.99
Actuate Therapeutics Inc Stock (ACTU) Company Profile
Firmenname
Actuate Therapeutics Inc
Sektor
Branche
Telefon
847-986-4190
Adresse
1751 RIVER RUN, FORT WORTH
Vergleichen Sie ACTU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACTU
Actuate Therapeutics Inc
|
6.469 | 155.73M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.89 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.28 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.29 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.00 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.07 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Actuate Therapeutics Inc Stock (ACTU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-26 | Eingeleitet | B. Riley Securities | Buy |
| 2025-04-22 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-17 | Eingeleitet | H.C. Wainwright | Buy |
Actuate Therapeutics Inc Aktie (ACTU) Neueste Nachrichten
Is it time to cut losses on Actuate Therapeutics Inc.Portfolio Profit Report & Technical Entry and Exit Alerts - newser.com
How Actuate Therapeutics Inc. stock compares to market leadersChart Signals & AI Optimized Trading Strategy Guides - newser.com
Using R and stats models for Actuate Therapeutics Inc. forecasting2025 Short Interest & Fast Gaining Stock Reports - newser.com
What’s next for Actuate Therapeutics Inc. stock priceEarnings Overview Report & Advanced Swing Trade Entry Plans - newser.com
Why Actuate Therapeutics Inc. stock could benefit from AI revolutionExit Point & Pattern Based Trade Signal System - newser.com
Real time scanner hits for Actuate Therapeutics Inc. explainedWall Street Watch & Daily Oversold Bounce Ideas - newser.com
How Actuate Therapeutics Inc. stock performs in high volatility markets2025 Top Gainers & Scalable Portfolio Growth Methods - newser.com
What indicators show strength in Actuate Therapeutics Inc.Global Markets & Long-Term Safe Investment Plans - newser.com
What makes Actuate Therapeutics Inc. stock attractive to growth fundsGlobal Markets & Free High Return Stock Watch Alerts - newser.com
Published on: 2025-11-01 09:18:34 - newser.com
Advanced analytics toolkit walkthrough for Actuate Therapeutics Inc.Earnings Summary Report & Weekly Stock Performance Updates - newser.com
Published on: 2025-10-31 03:58:11 - newser.com
Is Actuate Therapeutics Inc. building a consolidation baseExit Point & AI Driven Stock Movement Reports - newser.com
How Actuate Therapeutics Inc. stock benefits from tech adoptionEarnings Recap Summary & Daily Stock Trend Watchlist - newser.com
Is Actuate Therapeutics Inc. stock gaining market shareStop Loss & Weekly Watchlist for Hot Stocks - fcp.pa.gov.br
Actuate Therapeutics shares sink on pricing of $15M public offering of common stock - MSN
Is Actuate Therapeutics Inc. stock near bottom after decline2025 Major Catalysts & Stock Portfolio Risk Control - fcp.pa.gov.br
EMA gives OMPD to Actuate’s pancreatic cancer therapy - MSN
Published on: 2025-10-27 18:21:51 - newser.com
Strategies to average down on Actuate Therapeutics Inc.Bond Market & Real-Time Stock Price Movement Reports - newser.com
Finanzdaten der Actuate Therapeutics Inc-Aktie (ACTU)
Es liegen keine Finanzdaten für Actuate Therapeutics Inc (ACTU) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):